RADU, CLAUDIA-MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.239
EU - Europa 944
AS - Asia 870
SA - Sud America 23
AF - Africa 16
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.097
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.235
SG - Singapore 433
CN - Cina 335
IT - Italia 331
DE - Germania 168
FI - Finlandia 113
SE - Svezia 97
GB - Regno Unito 64
VN - Vietnam 53
FR - Francia 41
RU - Federazione Russa 35
HK - Hong Kong 28
UA - Ucraina 27
NL - Olanda 23
BR - Brasile 17
CI - Costa d'Avorio 12
IE - Irlanda 11
IN - India 11
AT - Austria 9
CH - Svizzera 7
CA - Canada 4
AR - Argentina 3
DK - Danimarca 3
ES - Italia 3
PL - Polonia 3
AU - Australia 2
BE - Belgio 2
CL - Cile 2
EU - Europa 2
IR - Iran 2
JP - Giappone 2
LT - Lituania 2
LU - Lussemburgo 2
CZ - Repubblica Ceca 1
ID - Indonesia 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
MA - Marocco 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SZ - Regno dello Swaziland 1
TR - Turchia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 8.097
Salva come PNG Salva come JPEG
Città #
Fairfield 1.000
Woodbridge 684
Chandler 540
Ashburn 496
Ann Arbor 466
Houston 393
Seattle 390
Wilmington 340
Cambridge 327
Singapore 210
Santa Clara 154
Boardman 139
Jacksonville 126
Padova 113
San Diego 102
Princeton 98
Beijing 94
Des Moines 68
Medford 68
Helsinki 65
Dong Ket 53
Roxbury 44
Milan 31
Nanjing 30
Villafranca Padovana 30
Hong Kong 28
London 22
Nuremberg 17
Shenyang 17
Falls Church 14
Nanchang 14
New York 14
Guangzhou 13
Abidjan 12
Jinan 12
Los Angeles 12
Hebei 11
Norwalk 10
Nürnberg 10
Dallas 9
Bologna 8
Changsha 8
Hefei 8
Chicago 7
Dublin 7
Falkenstein 7
Legnaro 7
Munich 7
Tianjin 7
Cagliari 6
Jiaxing 6
Kharkiv 6
Kilburn 6
Ogden 6
Portsmouth 6
Amsterdam 5
Kunming 5
North Bergen 5
Redwood City 5
Taiyuan 5
Washington 5
Basel 4
Ferentino 4
Frankfurt am Main 4
Shanghai 4
Trento 4
Chiswick 3
Detroit 3
Düsseldorf 3
Fossò 3
Gunzenhausen 3
Indiana 3
Lappeenranta 3
Martinsicuro 3
Ningbo 3
Rockville 3
Tivoli 3
Verona 3
Vienna 3
Afragola 2
Atlanta 2
Bassano Del Grappa 2
Borås 2
Boston 2
Brentwood 2
Brussels 2
Capriate San Gervasio 2
Cardano al Campo 2
Dearborn 2
Drohobych 2
Fortaleza 2
Haikou 2
Hangzhou 2
Lauterbourg 2
Luxembourg 2
Madrid 2
Maserà di Padova 2
Orange 2
Paris 2
Piacenza 2
Totale 6.509
Salva come PNG Salva come JPEG
Nome #
Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? 204
miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways 200
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity 186
Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients 178
Dynamics of circulating microparticles in obesity after weight loss 158
Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance 152
Potential role of thrombelastography in the monitoring of acquired factor VIII inhibitor hemophilia A: report on a 78-year-old woman with life-threatening bleedings. 143
X-linked thrombophilia with a mutant factor IX (factor IX Padua). 139
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 137
Macrophage-secreted myogenic factors: a promising tool for greatly enhancing the proliferative capacity of myoblasts in vitro and in vivo 133
Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role. 133
Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia 131
Microparticles as biomarkers of venous thromboembolic events 125
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 124
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 123
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms 122
Platelet factor V levels in moderate to severe congenital factor V deficiency. 121
Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells 121
Whole blood rotation thromboelastometry (ROTEM(®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V. 117
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. 116
Studies on coagulation incompatibilities for xenotransplantation. 112
Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events 112
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 112
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. 111
New prothrombin mutation (Arg596Trp, Prothrombin Padua 2) associated with venous thromboembolism 110
Effects of long-term administration of recombinant human protein C in xenografted primates. 108
Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: A role for circulating microparticles? 107
MP062 EXPLORING ALBUMIN UPTAKE IN HUMAN PODOCYTES: A POSSIBLE INVOLVEMENT FOR THE TUBULAR UPTAKE MACHINERY 107
Similar hypercoagulable state and thrombosis risk in type I and type III proteinS-deficient individuals from mixed type I/III families. 106
Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study 106
Tailored prophylaxis with rFXIII (NovoThirteen ® ) in a young girl with severe FXIII deficiency and previous cephalohaematoma 106
Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women 104
Enhancing myoblast proliferation by using myogenic factors: a promising approach for improving fiber regeneration in sport medicine and skeletal muscle diseases 102
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis 101
Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity. 100
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 98
Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. 96
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. 92
Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation. 90
Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolism. 90
The haemostatic system in acromegaly: a single-centre case–control study 90
Similar hypercoagulable state and thrombosis risk in type Iand type III protein S-deficient individuals from families with mixed type I/IIIprotein S deficiency. 89
Association between increased FVIIa-antithrombin complex/FVIIa ratio and pre-eclampsia. 89
Reference values for thromboelastometry (ROTEM®) in cynomolgus monkeys (Macaca fascicularis). 89
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 89
Critical review of the evolution of extracellular vesicles’ knowledge: From 1946 to today 89
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis 88
Inherited thrombophilia and venous thromboembolism 87
The aggressive EpCAM+CD45+ phenotype in serous epithelial ovarian cancer 85
The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells. 84
Circulating microparticles in carriers of prothrombin G20210A mutation. 84
Thromboelastometry profiles after “in vitro” addition of a new plasma-derived factor V concentrate to whole blood from parahaemophilia patients 84
Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation. 83
Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma 83
Circulating glial-derived and tissue factor bearing microparticles in patients with high grade glioma 82
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 81
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis 80
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study 79
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 77
Microvesicles in bronchoalveolar lavage as a potential biomarker of COPD 77
[Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases]. 75
Albumin uptake in human podocytes: A possible role for the cubilin-amnionless (CUBAM) complex 74
Incidence of VTE in asymptomatic children with deficiencies of antithrombin, protein C, and protein S: a prospective cohort study 72
Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: insights from renal ultrastructural findings.   71
Increased Cardiovascular Risk Associated with Chemical Sensitivity to Perfluoro-Octanoic Acid: Role of Impaired Platelet Aggregation 68
Levels of circulating microparticles in septic shock and sepsis-related complications: A case-control study 67
Whole blood coagulation assessment using novel rotational thromboelastometry (ROTEM-R) in seen naive cynomologus monkeys 64
Thrombin generation and thromboelastometry in monitoring the in-vitro reversal of warfarin: A comparison between 3-factor and 4-factor prothrombin complex concentrates 61
PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes. 61
Evaluation of necroptosis related genes RIPK1, RIPK3 and MLKL-p immunogenicity in hepatocellular carcinoma 60
Thrombin generation profile in cynomolgus monkey recipients of porcine neuronal xenograft 59
Poly(lipoic acid)-based nanoparticles as a new therapeutic tool for delivering active molecules 58
Sounds Stimulation on In Vitro HL1 Cells: A Pilot Study and a Theoretical Physical Model 57
The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings 57
Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases. 55
Study of the origin of platelets coagulation protein S by human megakaryocyte cultures and characterization of platelets protein S in patients with inherited protein S deficiency 53
Coagulation profile in cynomolgus monkey recipients of porcine neuronal xenograft: a preliminary study 51
CHARACTERIZATION OF CIRCULATING MICROPARTICLES DURING NORMAL PREGNANCY 49
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19 49
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 47
Exploring albumin uptake in human podocytes: a possible involvement of the tubular endocytic machinery 47
Necroptosis-driving genes RIPK1, RIPK3 and MLKL-p are associated with intratumoral CD3+ and CD8+ T cell density and predict prognosis in hepatocellular carcinoma 46
Exogenous human α-Synuclein acts in vitro as a mild platelet antiaggregant inhibiting α-thrombin-induced platelet activation 46
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 40
Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection 31
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 28
Macrophages-derived Factor XIII links coagulation to inflammation in COPD 26
Human parietal epithelial cells (PECs) and proteinuria in lupus nephritis: a role for ClC-5, megalin, and cubilin? 26
Increased Soluble Interleukin 6 Receptors in Fabry Disease 25
Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19 20
Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome 18
Anti-platelet factor 4 antibody-mediated disorders: an updated narrative review 17
Additive effect of Bisphenol A and Pefluoro-sulphoctanoic acid exposure at subacute toxic levels, on a murine model of sertoli cell 16
First Evidence of Mineralocorticoid Receptor Gene and Protein Expression in Rat and Human Thyroid Tissues and Cell Cultures 15
Human parietal epithelial cells as Trojan horses in albumin overload 8
Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology 6
Totale 8.245
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.240
article - articoli 32.111
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.351
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020521 0 0 0 0 0 0 0 0 200 174 80 67
2020/20211.368 49 89 107 96 81 55 52 153 152 223 132 179
2021/20221.244 52 73 160 92 95 103 39 170 78 26 101 255
2022/20231.043 175 115 31 143 174 115 6 71 136 11 51 15
2023/2024547 31 78 57 56 39 67 43 43 18 25 40 50
2024/20251.313 5 156 102 93 316 84 151 196 210 0 0 0
Totale 8.245